Add-on activity
This activity includes patient counseling videos.
Program Description
Atrial fibrillation (AF) is a common cardiac condition with increasing incidence and prevalence in the United States. People who have untreated AF are 5 times more likely to have a stroke; therefore, stroke prevention is essential to improve survival, health, and quality of life. Direct oral anticoagulants are crucial in the prevention of stroke and other life-threatening events for patients. Pharmacists should be educated on the recently updated 2023 ACC/AHA/ACCP/HRS Joint Committee Guideline for the Diagnosis and Management of Atrial Fibrillation so they can effectively manage anticoagulation therapies, promote medication adherence, and alleviate disease burden. This activity, which includes interactive patient case vignettes, will highlight the role of the pharmacist in assisting patients with AF, understanding the updated guidelines for treating AF, and implementing measures to reduce stroke risk.
Target audience: Health-system, consultant, and retail pharmacists
Type of activity: Application
Release date: June 7, 2024
Expiration date: June 24, 2025
Time to complete activity: 1.5 hours
Learner level: Foundational, Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain risk factors for atrial fibrillation (AF) and the importance of early interventions to reduce stroke risk in patients
- Explore recent guideline updates in the management of AF to ensure appropriate pharmacologic management
- Identify the role of the pharmacist in optimizing care for patients with AF
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
